BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38042266)

  • 21. Effects of the Sodium-Glucose Cotransporter Inhibitors on Cardiovascular Death and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Clinical Trials.
    Eraikhuemen N; Leung S; Warren SB; Lazaridis D; Smith CH; Kearson ML; Marcellus V
    Am J Cardiovasc Drugs; 2023 Mar; 23(2):113-126. PubMed ID: 36572841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart-Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke: Characteristics of Guideline-Recommended Coronary Revascularization and Antithrombotic Therapy and Cardiovascular and Bleeding Outcomes.
    Suzuki T; Kataoka Y; Shiozawa M; Morris K; Kiyoshige E; Nishimura K; Murai K; Sawada K; Iwai T; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Koga M; Ihara M; Toyoda K; Tsujita K; Noguchi T
    J Am Heart Assoc; 2023 Jan; 12(2):e027156. PubMed ID: 36645078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
    Hu WS; Lin CL
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1977-1986. PubMed ID: 36881169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis.
    Qiang JK; Alwithenani R; Uleryk E; Ezzat S; Lipscombe LL; Sawka AM
    Thyroid; 2023 Feb; 33(2):192-202. PubMed ID: 36074932
    [No Abstract]   [Full Text] [Related]  

  • 25. Associations of Menstrual Cycle Regularity and Length With Cardiovascular Diseases: A Prospective Study From UK Biobank.
    Huang C; Lin B; Yuan Y; Li K; Xu B; Zhang P; Wei X; Wang W; Liu W; Deng Y; Liu D; Lin J; Huang Y; Zhang H
    J Am Heart Assoc; 2023 Jun; 12(11):e029020. PubMed ID: 37222132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
    Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
    Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project.
    Sulo G; Igland J; Nygård O; Vollset SE; Ebbing M; Poulter N; Egeland GM; Cerqueira C; Jørgensen T; Tell GS
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28298373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of atopic dermatitis with stroke and myocardial infarction: A meta-analysis.
    Yuan M; Cao WF; Xie XF; Zhou HY; Wu XM
    Medicine (Baltimore); 2018 Dec; 97(49):e13512. PubMed ID: 30544450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverging trends for onset of acute myocardial infarction, heart failure, stroke and mortality in young males: role of changes in obesity and fitness.
    Åberg ND; Adiels M; Lindgren M; Nyberg J; Georg Kuhn H; Robertson J; Schaufelberger M; Sattar N; Åberg M; Rosengren A
    J Intern Med; 2021 Aug; 290(2):373-385. PubMed ID: 33826195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.
    Luo J; Xu S; Li H; Li Z; Liu B; Qin X; Gong M; Shi B; Wei Y
    ESC Heart Fail; 2020 Oct; 7(5):2762-2772. PubMed ID: 32578394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    J Clin Lipidol; 2024; 18(1):3-10. PubMed ID: 38061922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
    Graham DJ; Ouellet-Hellstrom R; MaCurdy TE; Ali F; Sholley C; Worrall C; Kelman JA
    JAMA; 2010 Jul; 304(4):411-8. PubMed ID: 20584880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
    Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; de Zeeuw D; Eckardt KU; McMurray JJV; Claggett B; Lewis EF; Pfeffer MA
    Am J Kidney Dis; 2017 Oct; 70(4):522-531. PubMed ID: 28599901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Matsuoka S; Kaneko H; Okada A; Itoh H; Suzuki Y; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Nakamura S; Node K; Yasunaga H; Komuro I
    Atherosclerosis; 2022 May; 348():68-74. PubMed ID: 35292151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.
    Kawabe A; Yasu T; Morimoto T; Tokushige A; Momomura SI; Sakakura K; Node K; Inoue T; Ueda S;
    ESC Heart Fail; 2021 Oct; 8(5):3748-3759. PubMed ID: 34268904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight variability and cardiovascular outcomes: a systematic review and meta-analysis.
    Massey RJ; Siddiqui MK; Pearson ER; Dawed AY
    Cardiovasc Diabetol; 2023 Jan; 22(1):5. PubMed ID: 36624453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis.
    Ng CYH; Tan BYQ; Teo YN; Teo YH; Syn NLX; Leow AST; Ho JSY; Chan MY; Wong RCC; Chai P; Chan ACY; Sharma VK; Yeo LLL; Sia CH; Ong JJY
    J Neurol; 2022 May; 269(5):2346-2358. PubMed ID: 34997286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.
    Kaze AD; Zhuo M; Kim SC; Patorno E; Paik JM
    Cardiovasc Diabetol; 2022 Mar; 21(1):47. PubMed ID: 35321742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social determinants of health and cardiovascular outcomes in patients with heart failure.
    Vinter N; Fawzy AM; Gent D; Ding WY; Johnsen SP; Frost L; Trinquart L; Lip GYH
    Eur J Clin Invest; 2022 Nov; 52(11):e13843. PubMed ID: 35924957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.